| 22.53 -0.94 (-4.01%) | 12-15 15:23 | |||||||||||||
|
|
| Short term | ||||
| Mid term | |
|||
| Targets | 6-month : | 27.45 |
1-year : | 29.9 |
| Resists | First : | 23.5 |
Second : | 25.6 |
| Pivot price | 22.58 |
|||
| Supports | First : | 20.12 | Second : | 16.73 |
| MAs | MA(5) : | 22.2 |
MA(20) : | 22.3 |
| MA(100) : | 27.55 |
MA(250) : | 0 | |
| MACD | MACD : | -1.2 |
Signal : | -1.5 |
| %K %D | K(14,3) : | 70 |
D(3) : | 58 |
| RSI | RSI(14): 43.5 |
|||
| 52-week | High : | 39.97 | Low : | 20.12 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ASTH ] has closed above bottom band by 48.6%. Bollinger Bands are 62% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 24.03 - 24.15 | 24.15 - 24.25 |
| Low: | 22.35 - 22.48 | 22.48 - 22.6 |
| Close: | 23.27 - 23.49 | 23.49 - 23.69 |
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
Sun, 14 Dec 2025
Is Astrana Health’s (ASTH) Bigger Bet on Full-Risk Deals Quietly Rewriting Its Earnings Story? - simplywall.st
Sun, 14 Dec 2025
Astrana Health (NASDAQ:ASTH) Now Covered by Needham & Company LLC - MarketBeat
Sat, 13 Dec 2025
Astrana Health (NASDAQ:ASTH) Trading Up 4.7% - Time to Buy? - MarketBeat
Fri, 12 Dec 2025
Astrana Health stock initiated as Buy at Needham (ASTH:NASDAQ) - Seeking Alpha
Fri, 12 Dec 2025
This QXO Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Thu, 11 Dec 2025
Thomas Lam At Astrana Health Capitalizes: Options Exercised, Resulting In $99K - Benzinga
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 50 (M) |
| Shares Float | 38 (M) |
| Held by Insiders | 22.1 (%) |
| Held by Institutions | 54.9 (%) |
| Shares Short | 2,380 (K) |
| Shares Short P.Month | 2,010 (K) |
| EPS | 0.18 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 15.69 |
| Profit Margin | 0.3 % |
| Operating Margin | 3 % |
| Return on Assets (ttm) | 2.8 % |
| Return on Equity (ttm) | 1.8 % |
| Qtrly Rev. Growth | 99.6 % |
| Gross Profit (p.s.) | 5.92 |
| Sales Per Share | 57.81 |
| EBITDA (p.s.) | 2.36 |
| Qtrly Earnings Growth | -97.7 % |
| Operating Cash Flow | 107 (M) |
| Levered Free Cash Flow | 208 (M) |
| PE Ratio | 118.68 |
| PEG Ratio | 0 |
| Price to Book value | 1.43 |
| Price to Sales | 0.39 |
| Price to Cash Flow | 10.61 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |